vaccine development!

22
Immune system overview in 10 minutes The non-immunologist guide to the immune system Morten Nielsen Department of Systems Biology DTU

Upload: tannar

Post on 23-Feb-2016

99 views

Category:

Documents


0 download

DESCRIPTION

Immune system overview in 10 minutes The non-immunologist guide to the immune system Morten Nielsen Department of Systems Biology DTU. Vaccine development!. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Vaccine development!

Immune system overview in 10 minutes

The non-immunologist guide to the immune system

Morten NielsenDepartment of Systems Biology

DTU

Page 2: Vaccine development!

Vaccine development!

The arm of Sarah Nelmes, a dairy maid, who had contracted cowpox. Jenner used material from her arm to vaccinate an eight year old boy, James Phipps. (1798).

Page 3: Vaccine development!

Vaccine review

Page 4: Vaccine development!

Vaccines can eradicate pathogens and save lives

Page 5: Vaccine development!

Vaccines have been made for 36 of >400 human pathogens

Immunological Bioinformatics, The MIT press.

+HPV & Rotavirus

Page 6: Vaccine development!

Immune system• Innate – fast…• Addaptive – remembers…

• Cellular• Cytotoxic T lymphocytes

(CTL)• Helper T lymphocytes (HTL)

• Humoral• B lymphocytes

Figure by Eric A.J. Reits

Epitopes

Page 7: Vaccine development!

MHC Class I pathway

Figure by Eric A.J. Reits

Page 8: Vaccine development!

MHC-I molecules present peptides on the surface of most cells

Figure courtesy Mette Voldby Larsen

Page 9: Vaccine development!

CTL response

Figure courtesy Mette Voldby Larsen

Page 10: Vaccine development!

Encounter with death

Page 11: Vaccine development!

Figure by Anne Mølgaard

Page 12: Vaccine development!

HLA binding motifSLLPAIVEL YLLPAIVHI TLWVDPYEV GLVPFLVSV KLLEPVLLL LLDVPTAAV LLDVPTAAV LLDVPTAAVLLDVPTAAV VLFRGGPRG MVDGTLLLL YMNGTMSQV MLLSVPLLL SLLGLLVEV ALLPPINIL TLIKIQHTLHLIDYLVTS ILAPPVVKL ALFPQLVIL GILGFVFTL STNRQSGRQ GLDVLTAKV RILGAVAKV QVCERIPTIILFGHENRV ILMEHIHKL ILDQKINEV SLAGGIIGV LLIENVASL FLLWATAEA SLPDFGISY KKREEAPSLLERPGGNEI ALSNLEVKL ALNELLQHV DLERKVESL FLGENISNF ALSDHHIYL GLSEFTEYL STAPPAHGVPLDGEYFTL GVLVGVALI RTLDKVLEV HLSTAFARV RLDSYVRSL YMNGTMSQV GILGFVFTL ILKEPVHGVILGFVFTLT LLFGYPVYV GLSPTVWLS WLSLLVPFV FLPSDFFPS CLGGLLTMV FIAGNSAYE KLGEFYNQMKLVALGINA DLMGYIPLV RLVTLKDIV MLLAVLYCL AAGIGILTV YLEPGPVTA LLDGTATLR ITDQVPFSVKTWGQYWQV TITDQVPFS AFHHVAREL YLNKIQNSL MMRKLAILS AIMDKNIIL IMDKNIILK SMVGNWAKVSLLAPGAKQ KIFGSLAFL ELVSEFSRM KLTPLCVTL VLYRYGSFS YIGEVLVSV CINGVCWTV VMNILLQYVILTVILGVL KVLEYVIKV FLWGPRALV GLSRYVARL FLLTRILTI HLGNVKYLV GIAGGLALL GLQDCTMLVTGAPVTYST VIYQYMDDL VLPDVFIRC VLPDVFIRC AVGIGIAVV LVVLGLLAV ALGLGLLPV GIGIGVLAAGAGIGVAVL IAGIGILAI LIVIGILIL LAGIGLIAA VDGIGILTI GAGIGVLTA AAGIGIIQI QAGIGILLAKARDPHSGH KACDPHSGH ACDPHSGHF SLYNTVATL RGPGRAFVT NLVPMVATV GLHCYEQLV PLKQHFQIVAVFDRKSDA LLDFVRFMG VLVKSPNHV GLAPPQHLI LLGRNSFEV PLTFGWCYK VLEWRFDSR TLNAWVKVVGLCTLVAML FIDSYICQV IISAVVGIL VMAGVGSPY LLWTLVVLL SVRDRLARL LLMDCSGSI CLTSTVQLVVLHDDLLEA LMWITQCFL SLLMWITQC QLSLLMWIT LLGATCMFV RLTRFLSRV YMDGTMSQV FLTPKKLQCISNDVCAQV VKTDGNPPE SVYDFFVWL FLYGALLLA VLFSSDFRI LMWAKIGPV SLLLELEEV SLSRFSWGAYTAFTIPSI RLMKQDFSV RLPRIFCSC FLWGPRAYA RLLQETELV SLFEGIDFY SLDQSVVEL RLNMFTPYINMFTPYIGV LMIIPLINV TLFIGSHVV SLVIVTTFV VLQWASLAV ILAKFLHWL STAPPHVNV LLLLTVLTVVVLGVVFGI ILHNGAYSL MIMVKCWMI MLGTHTMEV MLGTHTMEV SLADTNSLA LLWAARPRL GVALQTMKQGLYDGMEHL KMVELVHFL YLQLVFGIE MLMAQEALA LMAQEALAF VYDGREHTV YLSGANLNL RMFPNAPYLEAAGIGILT TLDSQVMSL STPPPGTRV KVAELVHFL IMIGVLVGV ALCRWGLLL LLFAGVQCQ VLLCESTAVYLSTAFARV YLLEMLWRL SLDDYNHLV RTLDKVLEV GLPVEYLQV KLIANNTRV FIYAGSLSA KLVANNTRLFLDEFMEGV ALQPGTALL VLDGLDVLL SLYSFPEPE ALYVDSLFF SLLQHLIGL ELTLGEFLK MINAYLDKLAAGIGILTV FLPSDFFPS SVRDRLARL SLREWLLRI LLSAWILTA AAGIGILTV AVPDEIPPL FAYDGKDYIAAGIGILTV FLPSDFFPS AAGIGILTV FLPSDFFPS AAGIGILTV FLWGPRALV ETVSEQSNV ITLWQRPLV

Page 13: Vaccine development!

Sequence logos•Height of a column equal to I•Relative height of a letter is p•Highly useful tool to visualize sequence motifs High information

positions

HLA-A0201

http://www.cbs.dtu.dk/biotools/Seq2Logo

Page 14: Vaccine development!

HLA polymorphism

Page 15: Vaccine development!

HLA specificity clustering

A0201

A0101

A0206

B0702

Page 16: Vaccine development!

More MHC molecules: more diversity in the presented peptides

• 1% probability that MHC molecule presents a peptide• Different hosts sample different peptides from same pathogen.

Page 17: Vaccine development!

Pathogen variability

• Pathogen variability– Millions of viral particles within a given

host• Pathogen diversity

– Different viral subtypes circulating in different parts of the world

Page 18: Vaccine development!

HIV subtypes (Gag protein)C

B

AE

AD

Page 19: Vaccine development!

Epitope identification

56 (1.5%) 9mer are conserved among all 15 Clade A gag

sequences

Page 20: Vaccine development!

Viral escape/variation

Figure courtesy Mette Voldby Larsen

?????

????

The virus of today is different from the virus of tomorrow (Viral escape)

Page 21: Vaccine development!

Vaccine design. Polytope construction

NH2 COOH

Epitope

Linker

M

C-terminal cleavage

Cleavage within epitopesNew epitopes

cleavage

Page 22: Vaccine development!

DNA vaccine